Michael Taylor
Net worth: - $ as of 2026-08-30
Net worth: - $ as of 2026-08-30
Mr. Michael Taylor is an Independent Director at NRX Pharmaceuticals, Inc. He is on the Board of Directors at NRX Pharmaceuticals, Inc. Mr. Taylor was previously employed as a Partner by Adi Dassler International Family Office LLC, a Managing Director by Oppenheimer & Co., Inc., and a MD-Institutional Fixed Income Trading by Stone & Youngberg LLC.
He received his undergraduate degree from London School of Economics & Political Science.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-02-11 | 0 ( -.--% ) | - $ | 2026-08-30 |
| Companies | Position | Start |
|---|---|---|
| NRX PHARMACEUTICALS, INC. | Director/Board Member | 2025-01-14 |
| Companies | Position | End |
|---|---|---|
Adi Dassler International Family Office LLC | Corporate Officer/Principal | 2023-02-13 |
Oppenheimer & Co., Inc.
Oppenheimer & Co., Inc. Investment ManagersFinance Provides wealth and asset management, brokerage & investment banking services | Corporate Officer/Principal | 2016-07-31 |
Stone & Youngberg LLC
Stone & Youngberg LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 2011-05-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Oppenheimer & Co., Inc.
Oppenheimer & Co., Inc. Investment ManagersFinance Provides wealth and asset management, brokerage & investment banking services | Finance |
Stone & Youngberg LLC
Stone & Youngberg LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
London School of Economics & Political Science
London School of Economics & Political Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adi Dassler International Family Office LLC | |
NRX Pharmaceuticals, Inc.
NRX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a molecule pharmaceutical company | Health Technology |
Select your edition
All financial news and data tailored to specific country editions